TARRYTOWN, N.Y., Jan. 7, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016. The presentation is scheduled for 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) and may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentation will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-34th-annual-jp-morgan-healthcare-conference-300200438.html
SOURCE Regeneron Pharmaceuticals, Inc.
